Senna Plus (Geri-Care Pharmaceutical Corp)
Welcome to the PulseAid listing for the Senna Plus drug offered from Geri-Care Pharmaceutical Corp. This pharmaceutical is classified as a HUMAN OTC DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN OTC DRUG drug type category.
LABELER NAME / MANUFACTURER: | Geri-Care Pharmaceutical Corp |
NON-PROPRIETARY NAME: | Sennosides and Docusate Sodium |
SUBSTANCE NAME: | SENNOSIDES; DOCUSATE SODIUM |
TYPE: | HUMAN OTC DRUG |
PHARMA CLASS: | |
ROUTE: | ORAL |
DOSAGE FORM: | TABLET |
MARKETING CATEGORY NAME: | OTC MONOGRAPH NOT FINAL |
START MARKETING DATE: | 2000-01-01 |
END MARKETING DATE: | 0000-00-00 |
Senna Plus HUMAN OTC DRUG Details:
Item Description | Senna Plus from Geri-Care Pharmaceutical Corp |
LABELER NAME: | Geri-Care Pharmaceutical Corp |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 8.6; 50(mg/1; mg/1) |
START MARKETING DATE: | 2000-01-01 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 57896-455_26f45960-e2f7-4585-811c-dedc6f18f8d4 |
PRODUCT NDC: | 57896-455 |
APPLICATION NUMBER: | part334 |
Other SENNOSIDES; DOCUSATE SODIUM Pharmaceutical Manufacturers / Labelers: